Skip to main content

The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

Publisher: International Union Against Tuberculosis and Lung Disease

More about this publication?
Volume 16, Number 5, 1 May 2012

editorial

Free Content How can this be? Preventing death in patients with HIV-associated tuberculosis [Editorial]
pp. 569-570(2)
Authors: Marston, Barbara J.; De Cock, Kevin M.

Favourites:
ADD

Free Content Treatment of MDR-TB: is hepatotoxicity a problem? [Editorial]
pp. 571-571(1)
Authors: Loddenkemper, Robert; Schaberg, Tom

Favourites:
ADD

Free Content Are national asthma programmes needed in resource-limited settings? [Editorial]
pp. 572-572(1)
Authors: Chiang, C-Y.; Bissell, K.; Perrin, C.

Favourites:
ADD

research-article

Free Content Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues [Perspectives]
pp. 573-578(6)
Authors: Kumar, A.; Kumar, A. M. V.; Gupta, D.; Kanchar, A.; Mohammed, S.; Srinath, S.; Tripathy, S.; Rajasekaran, S.; Chan, P-L.; Swaminathan, S.; Dewan, P. K.

Favourites:
ADD

review-article

Free Content NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis [Review article]
pp. 589-595(7)
Authors: Wang, P-Y.; Xie, S-Y.; Hao, Q.; Zhang, C.; Jiang, B-F.

Favourites:
ADD

research-article

Free Content Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome
pp. 596-603(8)
Authors: Keshavjee, S.; Gelmanova, I. Y.; Shin, S. S.; Mishustin, S. P.; Andreev, Y. G.; Atwood, S.; Furin, J. J.; Miller, A.

Favourites:
ADD

Free Content Clinical outcomes of pyrazinamide-monoresistant Mycobacterium tuberculosis in Quebec
pp. 604-609(6)
Authors: Yee, D. P.; Menzies, D.; Brassard, P.

Favourites:
ADD

Free Content Treatment of multidrug-resistant tuberculosis in a high-prevalence region through a binational consortium [Short communication]
pp. 610-611(2)
Authors: Laniado-Laborín, R.; Estrada-Guzman, J.; Perez, H.; Batiz-Armenta, F.; Alcantar-Schramm, J. M.

Favourites:
ADD

Free Content Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China [Short communication]
pp. 612-614(3)
Authors: Li, X.; Wang, H.; Jing, H.; Wang, Y.; Yu, C.; Wang, J.; Liu, Z.; Graviss, E. A.; Ma, X.

Favourites:
ADD

Free Content Integration of HIV testing in tuberculosis drug resistance surveillance in Kazakhstan and Kenya [Short communication]
pp. 615-617(3)
Authors: Klinkenberg, E.; van den Hof, S.; Tursynbayeva, A.; Kipruto, H.; Wahogo, J.; Pak, S.; Kutwa, A.; L'Herminez, R.

Favourites:
ADD

Free Content Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study
pp. 618-624(7)
Authors: Maruza, M.; Albuquerque, M. F. P. M.; Braga, M. C.; Barbosa, M. T. S.; Byington, R.; Coimbra, I.; Moura, L. V.; Batista, J. D. L.; Diniz, G. T. N.; Miranda-Filho, D. B.; Lacerda, H. R.; Rodrigues, L. C.; Ximenes, R. A. A.

Favourites:
ADD

Free Content Evaluation of integrated registers for tuberculosis and HIV surveillance in children, Ethiopia, 2007–2009 [Notes from the field]
pp. 625-627(3)
Authors: Click, E. S.; Feleke, B.; Pevzner, E.; Fantu, R.; Gadisa, T.; Assefa, D.; Melaku, Z.; Cain, K.; Menzies, H.

Favourites:
ADD

Free Content Value of different staging systems for predicting neurological outcome in childhood tuberculous meningitis
pp. 628-632(5)
Authors: van Toorn, R.; Springer, P.; Laubscher, J. A.; Schoeman, J. F.

Favourites:
ADD

Free Content Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial
pp. 633-638(6)
Authors: Chan, P-C.; Yang, C-H.; Chang, L-Y.; Wang, K-F.; Lu, B-Y.; Lu, C-Y.; Shao, P-L.; Hsueh, P-R.; Fang, C-T.; Huang, L-M.

Favourites:
ADD

Free Content Tuberculosis seasonality in the Netherlands differs between natives and non-natives: a role for vitamin D deficiency?
pp. 639-644(6)
Authors: Korthals Altes, H.; Kremer, K.; Erkens, C.; van Soolingen, D.; Wallinga, J.

Favourites:
ADD

Free Content Trends and challenges in tuberculosis in a medium-sized southern European setting [Notes from the field]
pp. 645-648(4)
Authors: Pasticci, M. B.; Mazzolla, R.; Mercuri, A.; Gamboni, G.; Bombaci, J. C.; Tiecco, C.; Rubeca, M.; Papili, R.; Pasticci, F.; Casali, L.; Ferrara, G.; Baldelli, F.

Favourites:
ADD

Free Content Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris
pp. 649-655(7)
Authors: Bernard, C.; Sougakoff, W.; Fournier, A.; Larnaudie, S.; Antoun, F.; Robert, J.; Brossier, F.; Truffot-Pernot, C.; Jarlier, V.; Veziris, N.

Favourites:
ADD

Free Content Interleukin-10 and interferon-gamma patterns during tuberculosis treatment: possible association with recurrence [Short communication]
pp. 656-659(4)
Authors: Lago, P. M.; Boéchat, N.; Migueis, D. P.; Almeida, A. S.; Lazzarini, L. C.; Saldanha, M. M.; Kritski, A. L.; Ho, J. L.; Lapa e Silva, J. R.

Favourites:
ADD

Free Content Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease
pp. 660-664(5)
Authors: Kitada, S.; Uenami, T.; Yoshimura, K.; Tateishi, Y.; Miki, K.; Miki, M.; Hashimoto, H.; Fujikawa, T.; Mori, M.; Matsuura, K.; Kuroyama, M.; Maekura, R.

Favourites:
ADD

Free Content Effective screening tool to triage recovery rooms for possible tuberculosis patients undergoing bronchoscopy
pp. 665-669(5)
Authors: Di Quinzio, M.; Alvarez, G. G.; Stockton, K.; Roth, V. R.

Favourites:
ADD

Free Content Triaging pandemic flu: pneumonia severity scores are not the answer
pp. 670-673(4)
Authors: Commons, R. J.; Denholm, J.

Favourites:
ADD

Free Content Peak expiratory flow as a screening tool to detect airflow obstruction in a primary health care setting
pp. 674-680(7)
Authors: Tian, J.; Zhou, Y.; Cui, J.; Wang, D.; Wang, X.; Hu, G.; Tian, Y.; Jiang, Y.; Zheng, J.; Wang, J.; Zhong, N.; Ran, P.

Favourites:
ADD

Free Content FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese
pp. 681-686(6)
Authors: Lam, D. C. L.; Fong, D. Y. T.; Yu, W. C.; Ko, F. W. S.; Lau, A. C. W.; Chan, J. W. M.; Choo, K. L.; Mok, T. Y. W.; Tam, C. Y.; Ip, M. S. M.; Chan-Yeung, M. M. W.

Favourites:
ADD

Free Content The challenges of replicating the methodology between Phases I and III of the ISAAC programme
pp. 687-693(7)
Authors: Ellwood, P.; Asher, M. I.; Stewart, A. W.; Aït-Khaled, N.; Mallol, J.; Strachan, D.; ISAAC Phase III Time Trends Study Group

Favourites:
ADD

Free Content Chronic obstructive pulmonary disease and metabolic syndrome: a nationwide survey in Korea
pp. 694-700(7)
Authors: Park, B. H.; Park, M. S.; Chang, J.; Kim, S. K.; Kang, Y. A.; Jung, J. Y.; Kim, Y. S.; Kim, C.

Favourites:
ADD

letter

Favourites:
ADD

reply

letter

Free Content Should Xpert® MTB/RIF be rolled out in low-income countries? [Correspondence]
pp. 702-703(2)
Authors: Peters, Dean; Theron, Grant; Peter, Jonny; Dheda, Keertan

Favourites:
ADD

reply

Free Content In reply to ‘Should Xpert® MTB/RIF be rolled out in low-income countries?’ [Correspondence]
pp. 703-704(2)
Authors: Trébucq, A.; Harries, A. D.; Rieder, H. L.

Favourites:
ADD

letter

Free Content Global laboratory initiative tool for a stepwise process towards tuberculosis laboratory accreditation [Correspondence]
pp. 704-705(2)
Authors: Datema, Tjeerd A. M.; Oskam, Linda; Engelberts, Mirjam F. M.; van Beers, Stella M.; Shinnick, Thomas M.; Baker, Martin; Ridderhof, John C.; Scholten, Jerod; van Deun, Armand; Gilpin, Christopher; Klatser, Paul R.

Favourites:
ADD

Free Content Line probe and automated real-time PCR TB assays warrant adherence to strict quality assurance measures [Correspondence]
pp. 705-706(2)
Authors: Somoskovi, Akos; Parsons, Linda M.; Gutierrez, Cristina; Lee, Evan; Salfinger, Max

Favourites:
ADD

Free Content Scientific and patient care evidence to change susceptibility breakpoints for first-line anti-tuberculosis drugs [Correspondence]
pp. 706-707(2)
Authors: Pasipanodya, Jotam G.; Srivastava, Shashikant; Gumbo, Tawanda

Favourites:
ADD

Free Content TB screening in an HIV clinic: how interferon-gamma assays improve screening compliance [Correspondence]
pp. 707-707(1)
Authors: O'Neal, Wesley T.; Winters, Matthew W.; Augustino, Kerri L.; Fang, Xiangming; Cook, Paul P.

Favourites:
ADD

Free Content Almost universal coverage: HIV testing among TB patients in a rural public programme [Correspondence]
pp. 708-708(1)
Authors: Chimbindi, Natsayi; Bärnighausen, Till; Newell, Marie-Louise

Favourites:
ADD

Free Content A presentation of Poncet's disease identified following immunosuppressive steroid therapy [Correspondence]
pp. 708-709(2)
Authors: Kasivisvanathan, V.; Connell, D. W.; Molyneaux, P. L.; Singanayagam, A.; George, P. M.; Tench, C.; Kon, O. M.

Favourites:
ADD

Free Content Geographic variability in COPD prevalence [Correspondence]
pp. 709-710(2)
Authors: Soriano, Joan B.; Lamprecht, Bernd

Favourites:
ADD

reply

Free Content In reply to ‘Geographic variability in COPD prevalence’ [Correspondence]
pp. 710-710(1)
Authors: Tan, Wan C.; Sin, Don D.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more